comparemela.com
Home
Live Updates
EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team - EyePoint Pharmaceuticals (NASDAQ:EYPT) : comparemela.com
EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team - EyePoint Pharmaceuticals (NASDAQ:EYPT)
– Stuart Duty appointed to EyePoint's Board of Directors – – George Elston promoted to Executive Vice President – WATERTOWN, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc.
Related Keywords
Massachusetts ,
United States ,
Watertown ,
Christina Tartaglia ,
George Elston ,
Jays Duker ,
Amy Phillips ,
Eyepoint Pharmaceuticals Inc ,
Occidental College ,
Guggenheim Securities ,
Betta Pharmaceuticals ,
Piper Jaffray ,
Juniper Pharmaceuticals Inc ,
Green Room Communications ,
Company Compensation Committee ,
Exchange Commission ,
Head Of Corporate Development ,
Pace University ,
Nasdaq ,
Harvard Business School ,
Optherion Inc ,
Pricewaterhousecoopers ,
Alimera Sciences ,
Head Of Corporate Development At Enzyvant Therapeutics ,
X Oncology Inc ,
Eyepoint Pharmaceuticals ,
Stuart Duty ,
Executive Vice President ,
Point Pharmaceuticals ,
Executive Vice ,
Chief Executive Officer ,
Senior Managing Director ,
Montgomery Securities ,
Oracle Partners ,
Harvard Business ,
Chief Financial ,
Chief Financial Officer ,
Corporate Development ,
Enzyvant Therapeutics ,
Juniper Pharmaceuticals ,
Certified Public ,
Board Member ,
Nasdaq Listing Rule ,
Term Incentive ,
Compensation Committee ,
Eyepoint Pharmaceutical ,
Private Securities Litigation Reform Act ,
Ocumension Therapeutics ,
Equinox Science ,
comparemela.com © 2020. All Rights Reserved.